Head-To-Head Contrast: Aspen Aerogels (NYSE:ASPN) and Bachem (OTCMKTS:BCHMF)

Bachem (OTCMKTS:BCHMF) and Aspen Aerogels (NYSE:ASPN) are both materials companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, earnings, risk, dividends, analyst recommendations, institutional ownership and valuation.

Valuation & Earnings

This table compares Bachem and Aspen Aerogels”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bachem	N/A	N/A	N/A	N/A	N/A
Aspen Aerogels	$271.10 million	1.59	-$389.55 million	($1.53)	-3.41

Bachem has higher earnings, but lower revenue than Aspen Aerogels.

Profitability

This table compares Bachem and Aspen Aerogels’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bachem	N/A	N/A	N/A
Aspen Aerogels	-62.45%	-31.12%	-17.33%

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Bachem and Aspen Aerogels, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bachem	1	0	3	0	2.50
Aspen Aerogels	2	1	4	0	2.29

Aspen Aerogels has a consensus target price of $5.94, suggesting a potential upside of 13.96%. Given Aspen Aerogels’ higher possible upside, analysts plainly believe Aspen Aerogels is more favorable than Bachem.

Institutional and Insider Ownership

97.6% of Aspen Aerogels shares are held by institutional investors. 3.0% of Aspen Aerogels shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Summary

Aspen Aerogels beats Bachem on 5 of the 9 factors compared between the two stocks.

About Bachem

Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland.

About Aspen Aerogels

Aspen Aerogels, Inc. designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier. The company offers PyroThin thermal barriers for use in lithium-ion batteries in electric vehicles and energy storage industries; Pyrogel XTE that reduces the risk of corrosion under insulation in energy infrastructure operating systems; and Pyrogel HPS for applications within the power generation market. It also offers Pyrogel XTF to provide protection against fire; Cryogel Z for sub-ambient and cryogenic applications in the energy infrastructure market; Spaceloft Subsea for use in pipe-in-pipe applications in offshore oil production; and Cryogel X201, which is used in designing cold systems, such as refrigerated appliances, cold storage equipment, and aerospace systems. The company was founded in 2001 and is headquartered in Northborough, Massachusetts.